Vanderbilt Ingram Cancer Center Archives

For more VICC news, visit their website »

Ginseng intake and mortality

Jun. 20, 2022—Regular ginseng intake, particularly over a long duration, is associated with decreased risk of death from all causes, Vanderbilt researchers discovered in a large epidemiological study.

Breast cancer biomarkers of response

Jun. 16, 2022—Vanderbilt researchers have identified blood-based biomarkers associated with complete responses to neoadjuvant chemotherapy in patients with breast cancer.

Conquer Cancer awards given to five hematology-oncology fellows

May. 26, 2022—Five Vanderbilt University Medical Center hematology and oncology fellows will receive awards from Conquer Cancer, the ASCO Foundation, during the 2022 American Society of Clinical Oncology Annual Meeting in Chicago, June 3-7.

Clarksville cancer center has new name

May. 19, 2022—The Vanderbilt-affiliated cancer center in Clarksville has a new name: Vanderbilt-Ingram Cancer Center at Tennova Healthcare – Clarksville (VICCTHC).

Shown at Monday’s VICC Annual Scientific Retreat are (front row, from left) Timothy Blackwell, MD, Fabien Maldonado, MD, Denise Aberle, MD, Melinda Aldrich, PhD, MPH, Kim Sandler, MD, (back row, from left) Eric Grogan, MD, MPH, Sudhir Srivastava, PhD, MPH, M. Patricia Rivera, MD, Julien Sage, PhD, David Carbone, MD, PhD, and Scott Hiebert, PhD.

VICC Scientific Retreat focuses on lung cancer

May. 5, 2022—by Tom Wilemon Speakers at the Vanderbilt-Ingram Cancer Center (VICC) 23rd Annual Scientific Retreat celebrated “Advances in Lung Cancer Research” but noted that too many people with the disease are not benefiting from those achievements. “Lung cancer is our leading cause of cancer mortality. Twenty-nine percent of our total cancers are lung cancer. That’s the...

Studies by Andrew Glazer, PhD, Giovanni Davogustto, MD, and colleagues found that genetic testing with information from electronic health records can reveal undiagnosed heart rhythm disorders.

Studies combine genetic testing, electronic health records to find undiagnosed diseases

Apr. 28, 2022—Combining genetic testing with information from electronic health records revealed undiagnosed heart rhythm disorders and new conditions associated with inherited cancer gene mutations.

Molecular testing across tumor types

Apr. 25, 2022—The KRAS inhibitor sotorasib is newly approved for one kind of lung cancer; Vanderbilt researchers ask if it should be considered for another type if the tumor has the gene mutation it targets.

A VUMC study found that following up with patients within the week after their hospital discharge as a stand-alone intervention has no impact on readmissions, mortality or patient satisfaction.

Financial impact of prior authorization

Apr. 12, 2022—Prior authorization — health insurer approval of a medical intervention prior to treatment — costs more than $40 million for U.S. academic radiation oncology practices, with questionable value added to patient care.

Clip In 4 the Cure

Mar. 31, 2022—More than 300 riders participated in the inaugural Clip In 4 the Cure, a relay-style, team cycling event that supported cancer initiatives at Vanderbilt-Ingram Cancer Center and Monroe Carell Jr. Children’s Hospital at Vanderbilt.

Black patients with cancer face worse COVID outcomes: study

Mar. 31, 2022—Vanderbilt researchers have found that Black patients with cancer experienced significantly worse outcomes after COVID-19 diagnosis than non-Hispanic white cancer patients.

Stress in young adult cancer patients and caregivers

Mar. 24, 2022—Adolescent and young adult oncology patients and caregivers experience psychosocial impairment and financial toxicity at the time of cancer diagnosis, findings that will inform interventions to support patient and caregiver well-being.